# SHR Predicts CMD in Patients with CCS

> **NCT06698432** · — · COMPLETED · sponsor: **Ya-Wei Xu** · enrollment: 379 (actual)

## Conditions studied

- Coronary Microvascular Dysfunction (CMD)
- Index of Microvascular Resistance
- Chronic Coronary Syndrome
- Prognosis

## Interventions

- **DEVICE:** caIMR

## Key facts

- **NCT ID:** NCT06698432
- **Lead sponsor:** Ya-Wei Xu
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06-01
- **Primary completion:** 2019-06-01
- **Final completion:** 2019-06-01
- **Target enrollment:** 379 (ACTUAL)
- **Last updated:** 2024-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06698432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06698432, "SHR Predicts CMD in Patients with CCS". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT06698432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*